SPARC gets orphan drug designation for Phenobarbital from US FDA Press Trust of India Oct 7, 2019 Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of…
Glenmark receives Orphan Drug Designation for GBR 1342 EP News Bureau Sep 17, 2019 The drug is indicated for the treatment of multiple myeloma Glenmark Pharmaceuticals (Glenmark), announced that the US Food and…
Stempeutics receives ODD in the European Union for Stempeucel Usha Sharma Jun 2, 2015 Stempeucel is used in the treatment of Thromboangiitis Obliterans
